UCSF

ZINC03830428

Substance Information

In ZINC since Heavy atoms Benign functionality
September 30th, 2005 35 No

Other Names:

(6R,7R)-7-[(2-hydroxy-2-phenylacetyl)amino]-8-oxo-3-[[1-(sulfomethyl)tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-[[(2R)-2-hydroxy-2-phenylacetyl]amino]-8-oxo-3-[[1-(sulfomethyl)tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-8-oxo-3-({[1-(sulfomethyl)-1H-tetrazol-5-yl]sulfanyl}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-8-oxo-3-({[1-(sulfomethyl)-1H-tetrazol-5-yl]sulfanyl}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefonicid

(6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-8-oxo-3-({[1-(sulfomethyl)-1H-tetrazol-5-yl]thio}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-8-oxo-3-({[1-(sulfonatomethyl)-1H-tetrazol-5-yl]sulfanyl}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

(7R)-7-(2-Hydroxy-2-phenylacetylamino)-6-oxo-3-{[1-(sulfomethyl)(1,2,3,4-tetraazol-5-ylthio)]methyl}-2H,7H,7aH-azetidino[2,1-b]1,3-thiazine-4-carboxylic acid

5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((hydroxyphenylacetyl)amino)-8-oxo-3-(((1-(sulfomethyl)-1H-tetrazol-5-yl)thio)methyl)-, (6R-(6alpha,7beta(R*)))-

5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((hydroxyphenylacetyl)amino)-8-oxo-3-(((1-(sulfomethyl)-1H-tetrazol-5-yl)thio)methyl)-, (6R-(6alpha,7beta(R*)))-; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((hydroxyphenylacetyl)amino

5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((hydroxyphenylacetyl)amino)-8-oxo-3-(((1-sulfomethyl)-1H-tetrazol-5-yl)thio)methyl)-, (6R-(6-alpha,7-beta(R*)))-

61270-58-4

61270-58-4; Cefonicid (INN); D07644; Monocef (TN)

61270-78-8 (di-hydrochloride salt)

61270-78-8; C08105; Cefonicid sodium

61270-78-8; Cefonicid sodium (USP); D00912; Monocid (TN)

6beta-[(2R)-2-hydroxy-2-phenylacetamido]-3-({[1-(sulfomethyl)-1H-tetrazol-5-yl]sulfanyl}methyl)ceph-3-em-4-carboxylic acid

7-[(2-hydroxy-2-phenylacetyl)amino]-8-oxo-3-[[1-(sulfomethyl)tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

AC1L2A76

AC1L2A7C

AC1NDR63

AC1Q6LOE

BIDD:GT0667

BRN 1066181

C06882

C18H18N6O8S3

cef-

Cefonicid

Cefonicid (BAN

Cefonicid (INN)

Cefonicid Monosodium Salt

Cefonicid Sodium

Cefonicid [INN:BAN]

cefonicid(2-)

cefonicid; cefonicido; cefonicidum

Cefonicido

Cefonicido [inn-spanish]

Cefonicido [inn-spanish];Cefonicidum [inn-latin]

Cefonicidum

Cefonicidum [inn-latin]

CHEBI:3491

CHEMBL1601

CID11006063

CID11307798

CID43592

CID43594

CID4630261

D07644

DAP001173

DB01328

INN); Cefonicid Sodium (FDA

LS-150074

LS-187318

MolPort-006-391-990

Monocef

Monocef (TN)

Monocid

Praticef

SK&F-75073

SK&F-D-75073-Z2

SK&F-D-75073-Z2; SK&F-D75073-Z

SKF-75073-2

Sodium Cefonicid

UNII-6532B86WFG

USAN

USAN); Cefonicid Monosodium (USAN)

USP

USP); Cefonicid Monosodium (USAN)

Download: MOL2 SDF SMILES Flexibase

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) -3.40 -11.2 -123.25 2 14 -2 210 540.561 9

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 8.95e-01 g/l DrugBank-approved
Therapy antibacterial SMDC Pharmakon

Activity (Go SEA)

Analogs ( Draw Identity 99% 90% 80% 70% )

No pre-computed analogs available. Try a structural similarity search.